<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-221-1-38-43</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2683</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Роль личностных факторов и качества жизни в метаболической компенсации сахарного диабета 1 типа у подростков</article-title><trans-title-group xml:lang="en"><trans-title>The role of personality factors and quality of life in the metabolic compensation of type 1 diabetes mellitus in adolescents</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7942-7271</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плаксина</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Plaksina</surname><given-names>A. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4013-0785</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитина</surname><given-names>И. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitina</surname><given-names>I. L.</given-names></name></name-alternatives><email xlink:type="simple">nikitina0901@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>01</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>38</fpage><lpage>43</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Плаксина А.О., Никитина И.Л., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Плаксина А.О., Никитина И.Л.</copyright-holder><copyright-holder xml:lang="en">Plaksina A.O., Nikitina I.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2683">https://www.nogr.org/jour/article/view/2683</self-uri><abstract><p>Растущая распространенность сахарного диабета 1 типа (СД1) в возрастной группе подростков и ухудшение гликемического контроля в подростковом возрасте ставят новые цели поиска факторов, которые оказывают влияние на степень метаболической компенсации у подростков. Цель. Сопоставить особенности личностного профиля и качества жизни (КЖ) с метаболической компенсацией у детей-подростков с СД1, использующих новые высокие технологии лечения (НВТ) - флеш-мониторинг гликемии (ФМГ), инсулиновую помпу с функцией предиктивной остановки до наступления гипогликемии (ИПФП). Материалы и методы. В исследовании приняло участие 78 детей с СД1 в возрасте 11-17 лет. Группа 1 включала 30 пациентов, использующих ФМГ, группа 2 - 48 пациентов, использующих ИПФП. Срок наблюдения за пациентами составил 3 месяца с момента начала применения НВТ. Метаболический контроль (МК) оценивался по показателям: уровень гликированного гемоглобина (HbA1c), время в целевом диапазоне (ВЦД), время выше целевого диапазона (ВВЦД), время ниже целевого диапазона (ВНЦД). Исследование личностных факторов проведено тестированием «Большая пятерка-детский вариант» (BFQ), опросником Ахенбаха, оценка КЖ проведена опросником KINDL. Результаты. Распределение пациентов 1 группы по степени компенсации на момент включения: 24 человека имели HbA1c&gt;7.0%, 6 человек - HbA1c&lt;7.0%. При оценке параметров МК на 2 визите через 3 месяца пациенты с HbA1c&gt;7.0% имели достоверно выше значение ВВЦД (р=0.003) и достоверно более низкое ВЦД (р=0.006) при сравнении с группой компенсированных детей по уровню HbA1c. Методом линейной регрессии была выявлена статистически достоверная ассоциация между выраженностью шкалы «открытость опыту», оцененной по опроснику BFQ, и уровнем HbA1c (b=-0,2464; p=0,006). Имеется статистически достоверная отрицательная связь (p&lt;0,05) между ВЦД и наличием у подростка агрессивного поведения (b=-2,754; p=0,028), проблем с мышлением (b=3,542; p=0,008), а также других соматических жалоб (b=-4,07; p=0,003). Распределение пациентов 2 группы по степени компенсации на 1 визите: 32 человека имели HbA1c&gt;7.0%, 16 человек - HbA1c&lt;7.0%. При оценке МК через 3 месяца у группы исходно компенсированных пациентов уровень ВЦД достоверно выше в сравнении с группой детей с HbA1c&gt;7.0% (p=0,003). Получены статистически достоверные ассоциации между КЖ (уровень физического благополучия пациента) и уровнем «социальных проблем» (b=-0,88; p=0,001). Установлена статистически достоверная отрицательная связь между КЖ по показателю «болезнь» и шкалами «добросовестность» (b=-0.177; p=0,03), «эмоциональная устойчивость» (b=-0.1043; p=0,022), а также положительная связь с уровнем экстраверсии (b=0.1712; p=0,016). Заключение. Новые высокие технологии терапии диабета имеют более высокую эффективность у ранее компенсированных пациентов. Подростки с СД1, имеющие более высокий интеллект, более творческие и креативные, имеют лучшую метаболическую компенсацию. Наличие большого количества соматических жалоб и более агрессивное поведение подростка сопряжено с худшей метаболической компенсацией. Параметры гликемического контроля не влияют на качество жизни подростков с диабетом. Однако некоторые свойства личности влияют на восприятие качества жизни.</p></abstract><trans-abstract xml:lang="en"><p>The growing prevalence of type 1 diabetes mellitus (T1D) in the adolescent age group and the deterioration of glycemic control in adolescence set new goals for the search for factors that affect the degree of metabolic compensation in adolescents. The purpose of the study. To compare the features of the personal profile and quality of life (QOL) with metabolic compensation in adolescent children with T1D using new high-tech treatment (NHTT) - flash monitoring of glycemia (FMG), an insulin pump with the function of predictive stop before the onset of hypoglycemia (IPPS). Materials and methods. The study involved 78 children with T1D aged 11-17 years. Group 1 included 30 patients using FMG, group 2 included 48 patients using IPPS. The follow-up period for patients was 3 months from the start of the use of NHTT. Metabolic control (MC) was assessed by the following indicators: glycated hemoglobin (HbA1c) level, time in range (TIR), time above range (TAR), time below range (TBR). The study of personal factors was conducted by testing the "Big Five Questionnaire" (BFQ), the Achenbach questionnaire, and the assessment of quality of life was conducted by the KINDL questionnaire. Results. The distribution of patients in group 1 according to the degree of compensation at the time of inclusion: 24 people had HbA1c&gt;7.0%, 6 people had HbA1c&lt;7.0%. When evaluating the parameters of MC at the 2nd visit after 3 months, patients with HbA1c&gt;7.0% had a significantly higher TAR (p=0.003) and a significantly lower TIR (p=0.006). The method of linear regression revealed a statistically significant association between the severity of the "openness" scale assessed by the BFQ and the HbA1c level (b=-0.2464; p=0.006). There is a statistically significant negative association (p&lt;0.05) between TIR and the presence of aggressive behavior in a teenager (b=-2.754; p=0.028), thought problems (b=3.542; p=0.008), as well as other somatic complaints (b=-4.07; p=0.003). The distribution of patients in 2 groups according to the degree of compensation at 1 visit: 32 people had HbA1c&gt;7.0%, 16 people had HbA1c&lt;7.0%. When assessing MC after 3 months, the group of initially compensated patients had a significantly higher level of TIR (p=0.003). Statistically significant associations were obtained between QOL (the level of physical well-being) and the level of "social problems" (b=-0.88; p=0.001). A statistically significant negative association was established between QOL in terms of "disease" and the scales "conscientiousness" (b=-0.177; p=0.03), "neuroticism" (b=-0.1043; p=0.022), and a positive association with the level of extraversion (b=0.1712; p=0.016). Conclusion. New high-tech diabetes therapies have higher efficacy in previously compensated patients. Adolescents with T1D who have higher intelligence, are more creative, have better metabolic compensation. The presence of a large number of somatic complaints and more aggressive behavior of a teenager is associated with worse metabolic compensation. Glycemic control parameters do not affect the quality of life of adolescents with diabetes. However, some personality traits affect the perception of quality of life.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 1 типа</kwd><kwd>подростки</kwd><kwd>метаболический контроль</kwd><kwd>качество жизни</kwd><kwd>личностный профиль</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 1 diabetes mellitus</kwd><kwd>adolescents</kwd><kwd>metabolic control</kwd><kwd>quality of life</kwd><kwd>personal profile</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">IDF DIABETES ATLAS 10-th edition 2021. Chapter 3. Global picture. Diabetes incidence and prevalence in children and adolescents. Available at: https://diabetesatlas.org/en/(accessed: 05.11.2023.)</mixed-citation><mixed-citation xml:lang="en">IDF DIABETES ATLAS 10-th edition 2021. Chapter 3. Global picture. Diabetes incidence and prevalence in children and adolescents. Available at: https://diabetesatlas.org/en/(accessed: 05.11.2023.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">de Bock M, Codner E, Craig ME, Huynh T, Maahs DM, Mahmud FH et al. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes. 2022;23(8):1270-1276. doi: 10.1111/ pedi.13455.</mixed-citation><mixed-citation xml:lang="en">de Bock M, Codner E, Craig ME, Huynh T, Maahs DM, Mahmud FH et al. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes. 2022;23(8):1270-1276. doi: 10.1111/ pedi.13455.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nikitina I.L., Plaksina A.O. Current opportunities for glycaemic control in children and adolescents with type 1 diabetes mellitus: the path to achieving a goal. Meditsinskiy sovet = Medical Council. 2023;(17):109-114. (In Russ.) doi: 10.21518/ ms2023-357.@@ Никитина ИЛ, Плаксина АО. Современные возможности контроля гликемии у детей и подростков с сахарным диабетом 1-го типа - путь к достижению цели. Медицинский совет. 2023;17(17):109-114. doi: 10.21518/ ms2023-357.</mixed-citation><mixed-citation xml:lang="en">Nikitina I.L., Plaksina A.O. Current opportunities for glycaemic control in children and adolescents with type 1 diabetes mellitus: the path to achieving a goal. Meditsinskiy sovet = Medical Council. 2023;(17):109-114. (In Russ.) doi: 10.21518/ ms2023-357.@@ Никитина ИЛ, Плаксина АО. Современные возможности контроля гликемии у детей и подростков с сахарным диабетом 1-го типа - путь к достижению цели. Медицинский совет. 2023;17(17):109-114. doi: 10.21518/ ms2023-357.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lori M. Laffel et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes. JAMA. 2020;323(23):2388-2396. doi: 10.1001/jama.2020.6940.</mixed-citation><mixed-citation xml:lang="en">Lori M. Laffel et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes. JAMA. 2020;323(23):2388-2396. doi: 10.1001/jama.2020.6940.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Roque Cardona-Hernandez et al. Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Diabetes Care. 2021 Mar; dc201674. doi: 10.2337/dc20-1674.</mixed-citation><mixed-citation xml:lang="en">Roque Cardona-Hernandez et al. Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Diabetes Care. 2021 Mar; dc201674. doi: 10.2337/dc20-1674.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Elaine E. Sanderson et al. Continuous Glucose Monitoring Improves Glycemic Outcomes in Children With Type 1 Diabetes: Real-world Data From a Population-Based Clinic. Diabetes Care. 2021;44:e1-e2. doi: 10.2337/dc21-0304.</mixed-citation><mixed-citation xml:lang="en">Elaine E. Sanderson et al. Continuous Glucose Monitoring Improves Glycemic Outcomes in Children With Type 1 Diabetes: Real-world Data From a Population-Based Clinic. Diabetes Care. 2021;44:e1-e2. doi: 10.2337/dc21-0304.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Laptev D.N., Bezlepkina O.B., Demina E.S., Malievskiy O.A., Nikitina I.L., Samoilova I.G., Peterkova V.A. Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia. Problems of Endocrinology. 2022;68(3):86-92. (In Russ.) doi: 10.14341/probl12877.@@ Лаптев Д.Н., Безлепкина О.Б., Демина Е.С., Малиевский О.А., Никитина И.Л., Самойлова Ю.Г., Петеркова В.А. Результаты клинической апробации системы FreeStyle Libre у детей с сахарным диабетом 1 типа: улучшение гликемического контроля в сочетании со снижением риска тяжелой гипогликемии и диабетического кетоацидоза. Проблемы Эндокринологии. 2022;68(3):86-92. doi: 10.14341/probl12877.</mixed-citation><mixed-citation xml:lang="en">Laptev D.N., Bezlepkina O.B., Demina E.S., Malievskiy O.A., Nikitina I.L., Samoilova I.G., Peterkova V.A. Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia. Problems of Endocrinology. 2022;68(3):86-92. (In Russ.) doi: 10.14341/probl12877.@@ Лаптев Д.Н., Безлепкина О.Б., Демина Е.С., Малиевский О.А., Никитина И.Л., Самойлова Ю.Г., Петеркова В.А. Результаты клинической апробации системы FreeStyle Libre у детей с сахарным диабетом 1 типа: улучшение гликемического контроля в сочетании со снижением риска тяжелой гипогликемии и диабетического кетоацидоза. Проблемы Эндокринологии. 2022;68(3):86-92. doi: 10.14341/probl12877.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Heiko Bratke et al. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population. Diabetes Ther. 2021;12:2571-2583. doi: 10.1007/s13300-021-01127-6.</mixed-citation><mixed-citation xml:lang="en">Heiko Bratke et al. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population. Diabetes Ther. 2021;12:2571-2583. doi: 10.1007/s13300-021-01127-6.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shulman R, Stukel TA, Miller FA, Newman A, Daneman D, Guttmann A. Insulin pump use and discontinuation in children and teens: a population-based cohort study in Ontario, Canada. Pediatr Diabetes. 2017;18 (1):33-44. doi: 10.1111/pedi.12353.</mixed-citation><mixed-citation xml:lang="en">Shulman R, Stukel TA, Miller FA, Newman A, Daneman D, Guttmann A. Insulin pump use and discontinuation in children and teens: a population-based cohort study in Ontario, Canada. Pediatr Diabetes. 2017;18 (1):33-44. doi: 10.1111/pedi.12353.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">O’Connor MR, Carlin K, Coker T, Zierler B, Pihoker C. Disparities in insulin pumptherapy persist in youth with type 1 diabetes despite rising overall pump use rates. J Pediatr Nurs, 2019;44:16-21. doi: 10.1016/j.pedn.2018.10.005.</mixed-citation><mixed-citation xml:lang="en">O’Connor MR, Carlin K, Coker T, Zierler B, Pihoker C. Disparities in insulin pumptherapy persist in youth with type 1 diabetes despite rising overall pump use rates. J Pediatr Nurs, 2019;44:16-21. doi: 10.1016/j.pedn.2018.10.005.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Foster N.C., Beck R.W., Miller K.M. et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019; 21(2):66-72. doi: 10.1089/dia.2018.0384.</mixed-citation><mixed-citation xml:lang="en">Foster N.C., Beck R.W., Miller K.M. et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019; 21(2):66-72. doi: 10.1089/dia.2018.0384.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Delamater A.M., de Wit M., McDarby V. et al. ISPAD clinical practice consensus guidelines 2018: psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2018;19(Suppl 27):237-249.</mixed-citation><mixed-citation xml:lang="en">Delamater A.M., de Wit M., McDarby V. et al. ISPAD clinical practice consensus guidelines 2018: psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2018;19(Suppl 27):237-249.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nikitina I.L., Kelmanson I.A. Health-related quality of life in 4-to-6-year-old children with type 1 diabetes mellitus estimated by children and their mothers. Eur J Pediatr. 2022 Feb;181(2):549-560. doi: 10.1007/s00431-021-04239-0.</mixed-citation><mixed-citation xml:lang="en">Nikitina I.L., Kelmanson I.A. Health-related quality of life in 4-to-6-year-old children with type 1 diabetes mellitus estimated by children and their mothers. Eur J Pediatr. 2022 Feb;181(2):549-560. doi: 10.1007/s00431-021-04239-0.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nikitina I.L., Plaksina A.O., Pirozhkova A.S., Kelmanson I.A. Influence of the personalities and adherence to therapy on the metabolic control type 1 diabetes in adolescents. Meditsinskiy sovet = Medical Council. 2022;(19):96-103. (In Russ.) doi: 10.21518/2079-701X-2022-16-19-96-103.@@ Никитина И.Л., Плаксина А.О., Пирожкова А.С., Кельмансон И.А. Характеристика профиля личности и приверженность к терапии как факторы прогноза компенсации сахарного диабета 1-го типа у подростков. Медицинский совет. 2022;16(19):96-103. doi: 10.21518/2079-701X-2022-16-19-96-103.</mixed-citation><mixed-citation xml:lang="en">Nikitina I.L., Plaksina A.O., Pirozhkova A.S., Kelmanson I.A. Influence of the personalities and adherence to therapy on the metabolic control type 1 diabetes in adolescents. Meditsinskiy sovet = Medical Council. 2022;(19):96-103. (In Russ.) doi: 10.21518/2079-701X-2022-16-19-96-103.@@ Никитина И.Л., Плаксина А.О., Пирожкова А.С., Кельмансон И.А. Характеристика профиля личности и приверженность к терапии как факторы прогноза компенсации сахарного диабета 1-го типа у подростков. Медицинский совет. 2022;16(19):96-103. doi: 10.21518/2079-701X-2022-16-19-96-103.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
